Search results
The Coronavirus SARS-CoV-2 (COVID-19) by nucleic acid amplification test is for in vitro diagnostic use under the FDA Emergency Use Authorization (EUA) for U.S. laboratories certified under CLIA to perform high complexity tests. This test has not been FDA cleared or approved.
May 12, 2023 · Updates as of June 16, 2021. Clarified the differences between laboratory-based and point-of-care NAATs. A Nucleic Acid Amplification Test, or NAAT, is a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19. NAATs detect genetic material (nucleic acids).
Details. LOINC®. Back to Top. 2019 Novel Coronavirus (COVID-19), NAA. TEST: 139900. CPT: 87635. Print Share Include LOINC® in print. Synonyms. 2019 Novel Coronavirus. COVID-19. SARS-CoV-2. Special Instructions. Please note: Labcorp does not currently collect specimens for this test.
- Examples of Screening Testing Include
- How to Conduct Screening Testing
- Settings to Prioritize For Screening Testing
Point-in-time screening testingSerial screening testingWhen screening testingis used, it should be applied to participants regardless of vaccination status. Any type of viral testcan be used for screening purposes; however, consider the characteristics (including accessibility, accuracy and efficiency) of different test types to determine which best suits screening testing needs. People without symptom...
Settings that should be prioritized for screening testinginclude facilities and situations where transmission risk is high and the population served is at high risk of severe outcomes from COVID-19 or there is limited access to healthcare, including: 1. Specific settings that have demonstrated high potential for rapid and widespread virus spread to...
Dec 20, 2023 · For diagnosing current SARS-CoV-2 infection, the Centers for Disease Control and Prevention (CDC) recommends using either a nucleic acid amplification test (NAAT) or an antigen test. 1 Testing may also be used for screening and to determine the length of a patient’s isolation period. 2 There may be a window period of up to 5 days after ...
Test Details. Methodology. Nucleic Acid Amplification Test (NAAT) includes RT-PCR or TMA. Assay Category. This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories. Reference Range (s) Not detected. Alternative Name (s) Novel Coronavirus,Wuhan,COVID19,nCOV,Coronavirus.
Apr 15, 2021 · Molecular and antigen tests can detect current SARS-CoV-2 infection and are used to diagnose COVID-19. Clinicians should consider a test's characteristics, test timing in relation to...
